717 related articles for article (PubMed ID: 27035653)
21. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis.
Fan R; Li X; Gu X; Chan JC; Xu G
Diabetes Obes Metab; 2010 Sep; 12(9):815-24. PubMed ID: 20649634
[TBL] [Abstract][Full Text] [Related]
22. Activation of GLP-1 and gastrin signalling induces in vivo reprogramming of pancreatic exocrine cells into beta cells in mice.
Sasaki S; Miyatsuka T; Matsuoka TA; Takahara M; Yamamoto Y; Yasuda T; Kaneto H; Fujitani Y; German MS; Akiyama H; Watada H; Shimomura I
Diabetologia; 2015 Nov; 58(11):2582-91. PubMed ID: 26290048
[TBL] [Abstract][Full Text] [Related]
23. Suppression of Rho-kinase 1 is responsible for insulin regulation of the AMPK/SREBP-1c pathway in skeletal muscle cells exposed to palmitate.
Tang S; Wu W; Tang W; Ge Z; Wang H; Hong T; Zhu D; Bi Y
Acta Diabetol; 2017 Jul; 54(7):635-644. PubMed ID: 28265821
[TBL] [Abstract][Full Text] [Related]
24. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.
Liu Z; Habener JF
J Biol Chem; 2008 Mar; 283(13):8723-35. PubMed ID: 18216022
[TBL] [Abstract][Full Text] [Related]
25. Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway.
Chen K; Zhao L; He H; Wan X; Wang F; Mo Z
Int J Mol Med; 2014 Oct; 34(4):1073-80. PubMed ID: 25109869
[TBL] [Abstract][Full Text] [Related]
26. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
27. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
28. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells.
Peyot ML; Gray JP; Lamontagne J; Smith PJ; Holz GG; Madiraju SR; Prentki M; Heart E
PLoS One; 2009 Jul; 4(7):e6221. PubMed ID: 19593440
[TBL] [Abstract][Full Text] [Related]
30. B-cell translocation gene 2 positively regulates GLP-1-stimulated insulin secretion via induction of PDX-1 in pancreatic β-cells.
Hwang SL; Kwon O; Kim SG; Lee IK; Kim YD
Exp Mol Med; 2013 May; 45(5):e25. PubMed ID: 23703573
[TBL] [Abstract][Full Text] [Related]
31. Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells.
Wang H; Iezzi M; Theander S; Antinozzi PA; Gauthier BR; Halban PA; Wollheim CB
Diabetologia; 2005 Apr; 48(4):720-31. PubMed ID: 15756539
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
[TBL] [Abstract][Full Text] [Related]
33. Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.
Li L; El-Kholy W; Rhodes CJ; Brubaker PL
Diabetologia; 2005 Jul; 48(7):1339-49. PubMed ID: 15902400
[TBL] [Abstract][Full Text] [Related]
34. Exendin-4 stimulates autophagy in pancreatic β-cells via the RAPGEF/EPAC-Ca
Zummo FP; Krishnanda SI; Georgiou M; O'Harte FP; Parthsarathy V; Cullen KS; Honkanen-Scott M; Shaw JA; Lovat PE; Arden C
Autophagy; 2022 Apr; 18(4):799-815. PubMed ID: 34338148
[TBL] [Abstract][Full Text] [Related]
35. Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues.
Tews D; Werner U; Eckel J
Horm Metab Res; 2008 Mar; 40(3):172-80. PubMed ID: 18348079
[TBL] [Abstract][Full Text] [Related]
36. Atrial natriuretic peptide promotes pancreatic islet beta-cell growth and Akt/Foxo1a/cyclin D2 signaling.
You H; Laychock SG
Endocrinology; 2009 Dec; 150(12):5455-65. PubMed ID: 19837876
[TBL] [Abstract][Full Text] [Related]
37. Effect of exercise and insulin on SREBP-1c expression in human skeletal muscle: potential roles for the ERK1/2 and Akt signalling pathways.
Boonsong T; Norton L; Chokkalingam K; Jewell K; Macdonald I; Bennett A; Tsintzas K
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1310-1. PubMed ID: 17956338
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
[TBL] [Abstract][Full Text] [Related]
39. Exendin-4 inhibits glucolipotoxic ER stress in pancreatic β cells via regulation of SREBP1c and C/EBPβ transcription factors.
Oh YS; Lee YJ; Kang Y; Han J; Lim OK; Jun HS
J Endocrinol; 2013 Mar; 216(3):343-52. PubMed ID: 23257266
[TBL] [Abstract][Full Text] [Related]
40. Sterol regulatory element-binding protein-1c and pancreatic beta-cell dysfunction.
Shimano H; Amemiya-Kudo M; Takahashi A; Kato T; Ishikawa M; Yamada N
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():133-9. PubMed ID: 17919187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
